FI103867B1 - Menetelmä di-linoleoyyli-mono-gamma-linolenyyli-glyserolia sisältävän, farmaseuttisesti käyttökelpoisen öljyn valmistamiseksi - Google Patents

Menetelmä di-linoleoyyli-mono-gamma-linolenyyli-glyserolia sisältävän, farmaseuttisesti käyttökelpoisen öljyn valmistamiseksi

Info

Publication number
FI103867B1
FI103867B1 FI922542A FI922542A FI103867B1 FI 103867 B1 FI103867 B1 FI 103867B1 FI 922542 A FI922542 A FI 922542A FI 922542 A FI922542 A FI 922542A FI 103867 B1 FI103867 B1 FI 103867B1
Authority
FI
Finland
Prior art keywords
glycerol
linoleoyl
linolenyl
gamma
mono
Prior art date
Application number
FI922542A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI103867B (fi
FI922542A0 (fi
FI922542L (fi
Inventor
David Frederick Horrobin
Yung-Sheng Huang
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of FI922542A0 publication Critical patent/FI922542A0/fi
Publication of FI922542L publication Critical patent/FI922542L/fi
Application granted granted Critical
Publication of FI103867B publication Critical patent/FI103867B/fi
Publication of FI103867B1 publication Critical patent/FI103867B1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Edible Oils And Fats (AREA)
  • Logic Circuits (AREA)
  • Amplifiers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI922542A 1991-06-03 1992-06-02 Menetelmä di-linoleoyyli-mono-gamma-linolenyyli-glyserolia sisältävän, farmaseuttisesti käyttökelpoisen öljyn valmistamiseksi FI103867B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9111900 1991-06-03
GB919111900A GB9111900D0 (en) 1991-06-03 1991-06-03 Fatty acid compositions

Publications (4)

Publication Number Publication Date
FI922542A0 FI922542A0 (fi) 1992-06-02
FI922542L FI922542L (fi) 1992-12-04
FI103867B FI103867B (fi) 1999-10-15
FI103867B1 true FI103867B1 (fi) 1999-10-15

Family

ID=10695999

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922542A FI103867B1 (fi) 1991-06-03 1992-06-02 Menetelmä di-linoleoyyli-mono-gamma-linolenyyli-glyserolia sisältävän, farmaseuttisesti käyttökelpoisen öljyn valmistamiseksi

Country Status (20)

Country Link
US (4) US5328691A (enExample)
EP (1) EP0520624B1 (enExample)
JP (1) JP2704922B2 (enExample)
KR (2) KR100274727B1 (enExample)
AT (1) ATE136214T1 (enExample)
AU (1) AU652827B2 (enExample)
CA (1) CA2069600C (enExample)
DE (1) DE69209571T2 (enExample)
DK (1) DK0520624T3 (enExample)
ES (1) ES2085567T3 (enExample)
FI (1) FI103867B1 (enExample)
GB (1) GB9111900D0 (enExample)
GR (1) GR3019840T3 (enExample)
HK (1) HK4597A (enExample)
IE (1) IE75224B1 (enExample)
NO (1) NO180804C (enExample)
NZ (1) NZ242898A (enExample)
SG (1) SG49739A1 (enExample)
TW (1) TW288975B (enExample)
ZA (1) ZA923913B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
FR2706304B1 (fr) * 1993-06-15 1995-09-01 Carita Sa Utilisation des huiles de Chaulmoogra dans le domaine cosmétique et pharmaceutique, notamment en dermatologie, pour harmoniser la pigmentation de la peau.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
EP0707850A1 (en) * 1994-09-21 1996-04-24 Scotia Holdings Plc Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5639460A (en) * 1995-06-07 1997-06-17 Raymond; Hal C. Aqueous plant extract having antiviral activity
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
EP2280062A3 (en) * 1996-03-28 2011-09-28 DSM IP Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US6255505B1 (en) 1996-03-28 2001-07-03 Gist-Brocades, B.V. Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
CA2250575C (en) * 1996-03-28 2007-07-24 Gist-Brocades B.V. Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
EP0996482B1 (en) * 1997-07-16 2007-02-14 Metacure NV Smooth muscle controller
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
DE60130007T2 (de) 2000-06-27 2008-04-30 Qualilife Pharmaceuticals Inc. Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
EP3750406A1 (en) 2002-06-19 2020-12-16 DSM IP Assets B.V. Pasteurisation process for microbial cells and microbial oil
WO2004012753A1 (en) * 2002-07-31 2004-02-12 Helfried Hans Rudolf Crede Pharmaceutical composition containing black cumin oil, flax oil and borago oil
US7255972B2 (en) 2002-10-23 2007-08-14 Az Electronic Materials Usa Corp. Chemically amplified positive photosensitive resin composition
CN1816287A (zh) * 2003-01-31 2006-08-09 宝洁公司 改善哺乳动物角质组织外观的方法
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
GB2422373B (en) 2003-08-18 2008-05-21 Btg Int Ltd Treatment of neurodegenerative conditions
JP2006061021A (ja) * 2004-08-24 2006-03-09 Suntory Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP2010042037A (ja) * 2009-11-26 2010-02-25 Suntory Holdings Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
CN105899485B (zh) 2013-11-15 2018-10-19 尊严科学有限公司 多不饱和羟基脂肪酸的药学上可接受的盐
WO2015185698A1 (en) 2014-06-04 2015-12-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same
JP6816012B2 (ja) * 2015-03-26 2021-01-20 ティベリオ ブリュジーズ 多価不飽和脂肪酸の精製方法
JP2018524274A (ja) 2015-05-13 2018-08-30 ディーエス バイオファーマ リミテッド １５−オキソ−ｅｐａまたは１５−オキソ−ｄｇｌａを含む組成物、ならびにその作製及び使用方法
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172149A (en) * 1978-01-30 1979-10-23 Westwood Pharmaceuticals, Inc. Method for treating living skin exhibiting excessive sebum secretion
DE2942021A1 (de) * 1979-10-17 1981-04-30 Bristol Myers Co Dermatologisches mittel
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
US5011855A (en) * 1982-04-16 1991-04-30 Nestec S.A. Cosmetic and dermatological compositions containing γ-linolenic acid
EP0093516B1 (en) * 1982-04-29 1986-10-01 Efamol Limited Pharmaceutical composition
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2569347B1 (fr) * 1984-08-22 1987-10-23 Mollet Marc Composition lipidique favorisant la pousse des phaneres et produits cosmetiques en renfermant
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
FR2588187B1 (fr) * 1985-10-07 1989-04-14 Rochas Parfums Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
JPS6284041A (ja) * 1985-10-08 1987-04-17 Nitto Electric Ind Co Ltd γ−リノレン酸含有包接物
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
JPH0832628B2 (ja) * 1986-12-17 1996-03-29 株式会社ミドリ十字 トリグリセリド組成物
JPS6451496A (en) * 1987-08-21 1989-02-27 Nippon Oils & Fats Co Ltd Method of refining oil containing gamma-linolenic acid
FR2623692B1 (fr) * 1987-11-30 1991-05-03 Vernin Jean Gilles Nouvelle huile dietetique
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
US5116871A (en) * 1988-09-13 1992-05-26 Efamol Holdings Plc Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy

Also Published As

Publication number Publication date
GB9111900D0 (en) 1991-07-24
NO180804B (no) 1997-03-24
JP2704922B2 (ja) 1998-01-26
FI103867B (fi) 1999-10-15
KR100274727B1 (ko) 2000-12-15
CA2069600A1 (en) 1992-12-04
US5328691A (en) 1994-07-12
SG49739A1 (en) 1998-06-15
NZ242898A (en) 1994-12-22
IE75224B1 (en) 1997-08-27
FI922542A0 (fi) 1992-06-02
US5552150A (en) 1996-09-03
ES2085567T3 (es) 1996-06-01
HK4597A (en) 1997-01-17
AU652827B2 (en) 1994-09-08
NO922183L (no) 1992-12-04
CA2069600C (en) 2004-05-04
EP0520624A1 (en) 1992-12-30
US5620701A (en) 1997-04-15
IE921663A1 (en) 1992-12-16
KR100277424B1 (ko) 2000-12-15
US5614208A (en) 1997-03-25
TW288975B (enExample) 1996-10-21
DE69209571D1 (de) 1996-05-09
GR3019840T3 (en) 1996-08-31
FI922542L (fi) 1992-12-04
NO180804C (no) 1997-07-02
NO922183D0 (no) 1992-06-02
KR930000664A (ko) 1993-01-15
DK0520624T3 (da) 1996-05-06
ZA923913B (en) 1993-02-24
ATE136214T1 (de) 1996-04-15
AU1727892A (en) 1992-12-10
DE69209571T2 (de) 1996-09-05
JPH05201924A (ja) 1993-08-10
EP0520624B1 (en) 1996-04-03

Similar Documents

Publication Publication Date Title
FI103867B1 (fi) Menetelmä di-linoleoyyli-mono-gamma-linolenyyli-glyserolia sisältävän, farmaseuttisesti käyttökelpoisen öljyn valmistamiseksi
ES2094788T3 (es) Composicion nutritiva.
ZA896885B (en) Cosmetic composition
DE69108854D1 (de) Haarbehandlungsmittel.
DK0841892T3 (da) Hårpræparat på basis af Minoxidil med et lavt indhold af fedt opløsningsmiddel
NO893628D0 (no) Biocid preparat.
DE68906011D1 (de) Chitosan enthaltendes kosmetisches praeparat.
DK0631772T3 (da) Retinoidholdig sammensætning
NZ240011A (en) Oil-in-water emulsion nutritional composition: processes for production
ATE139435T1 (de) Kosmetische und dermatologische zubereitungen
ZA91115B (en) Topical compositions
FI842612A0 (fi) Framstaellning av etofenomat.
FR2627060B1 (fr) Creme fraiche modifiee et beurre enrichi a l'huile vegetale